fashion -WSS

fashion

author：Wikipedia 2025-09-28 02:27:14 - browse：24828

Matts Take Column Illustration — Molly Ferguson for STAT

If you’re a drug company executive, you probably feel like you got up on the wrong side of bed.

On Thursday night, President Biden proposed expanding one of his most popular policies: the Medicare price negotiation process that was put in place as part of the Inflation Reduction Act. “Americans pay more for prescription drugs than anywhere else,” Biden said. “It’s wrong and I’m ending it.”

Obviously, the drug industry is not going to be happy about new price limitations in the U.S., the biggest market for pharmaceuticals. But, even more than that, Biden’s move emphasizes a painful reality: That pharmaceutical companies remain one of the biggest political targets in the country — despite their key role in addressing the Covid-19 pandemic and their development of wildly effective new weight loss drugs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Prime Medicine, Myeloid Therapeutics clash over genome

WSS

Medicare Advantage beneficiaries sue Humana over algorithm use

Bristol Myers buys into radiopharmaceuticals with RayzeBio

CRISPR gene editing developments we’re watching in 2024

Takeda, Janssen join wearable maker to measure scratching

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

BIO selects John Crowley as new CEO

focus

fashion

knowledge

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Takeda, Janssen join wearable maker to measure scratching

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

How to keep neuroscience’s past racism from being its future

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Flagship Pioneering launches a new biotech in two countries

Peter Hotez and the public health issue of online harassment

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

The high cost of giving birth even with insurance

The EPA's new lead rule: How one expert crunched the numbers

leisure time

HCA sued by state AG for quality issues at Mission Health

Carvykti CAR

Hospitals owned by private equity see complications spike 25%

BIO selects John Crowley as new CEO

Pediatric cancer treatments threatened by a new FDA policy

Despite FDA concern, risk that CAR

hotspot

hotspot

knowledge

explore